Health Canada's Cosmetic Ingredient Hotlist Explained

Health Canada's Cosmetic Ingredient Hotlist is one of the most frequently misread documents in cosmetics regulatory affairs. It is not a regulation. It has no schedule number, no coming-into-force date, and it is not something a manufacturer can cite in a legal defence on its own. Yet inspectors use it every day to decide whether a product on Canadian shelves is compliant. Understanding what the Hotlist actually is - and is not - changes how you should use it.

What the Hotlist legally is

Canada's cosmetics law lives in two places: the Food and Drugs Act (FDA) and the Cosmetic Regulations made under it. Section 16 of the FDA is the operative rule - it prohibits the sale of any cosmetic that contains a substance which may injure the health of the user when the cosmetic is used according to its labelling, or for the purposes and in the manner customarily intended. That single sentence, not the Hotlist, is what a cosmetic sold in Canada must satisfy.

The Hotlist is Health Canada's own description: an administrative tool used to communicate to manufacturers, importers and other stakeholders which substances Health Canada considers would cause a cosmetic to contravene section 16 of the FDA or a provision of the Cosmetic Regulations if present. It translates a broad, open-textured safety prohibition into a substance-by-substance list that a formulator can actually check a product against. Health Canada is explicit that it can act against a product at any time under the FDA and the Cosmetic Regulations, regardless of whether a given substance already appears on the Hotlist - the list is a compliance aid, not the exhaustive boundary of what is unsafe.

That distinction matters in practice. A substance's absence from the Hotlist is not a safety finding and not permission to use it. It only means Health Canada has not (yet) chosen to flag that substance through this particular administrative channel. cosingchecker.com/regulations/ca/ carries this same caveat on every imported record: an entry is evidence of what Health Canada has published, not a guarantee of a product's overall legal status in Canada.

Prohibited vs restricted listings

The Hotlist is split into two lists with different legal consequences.

• Prohibited ingredients: substances Health Canada states should not be present at all in a cosmetic sold in Canada, including their synonyms, salts and related compounds.
• Restricted ingredients: substances that are permitted only if specific conditions - concentration limits, permitted product types, and/or mandatory cautionary statements - are met.

The current dataset on cosingchecker.com/regulations/ca/, imported from the Health Canada Hotlist dated 2025-08-13, holds 580 entries: 490 prohibited and 90 restricted. That split is worth noting for anyone used to the EU structure, where Annex II (banned substances) is roughly 4.7 times the size of Annex III (restricted substances) - Canada's prohibited-to-restricted ratio is even more skewed, at roughly 5.4 to 1.

How restrictions are expressed

Restricted entries on the Hotlist are not simple one-line concentration caps. They typically combine a permitted product-type list, a maximum concentration tied to each product type, and required warning statements, all inside a single substance entry. Three real entries from the current dataset illustrate the pattern.

Formaldehyde (CAS 50-00-0) is restricted, not prohibited, in Canada. It is not permitted in aerosol products at all. In non-aerosol products that release formaldehyde vapours under normal use, the cap is 0.01%. In oral products the cap is 0.1%. As a preservative in other non-oral products the cap is 0.2%. In nail hardeners it rises to 5.0%, but only if the product is sold with nail shields, directions for use, and the warning that the product contains formaldehyde with the potential to cause skin sensitivity.

Hydroquinone (CAS 123-31-9) is restricted for three separate uses: as an oxidizing colouring agent in hair dyes (0.3% maximum, with a combined-ingredient cap alongside p-hydroxyanisole of 0.1% if both are used together), in nail products (0.1%), and in cyanoacrylate adhesives for eyelash and eyebrow extensions (0.1%), each carrying its own warning statement about skin and eye contact.

Triclosan (CAS 3380-34-5) is capped at 0.03% in mouthwashes and 0.3% in other cosmetics, with additional purity requirements: manufacturers must keep the levels of polychlorinated dibenzo-p-dioxin and dibenzofuran impurities in the raw material below defined thresholds and hold raw-material specifications and analytical method documentation on file. Mouthwash and other oral products must also carry an under-12 warning.

This layered format - product type, concentration, and warning text bundled into one entry - is why a flat concentration number pulled out of context can be misleading. The condition only applies to the product type it is paired with.

How often the Hotlist changes

Health Canada states that the Hotlist is reviewed and updated periodically, as new scientific data becomes available - there is no fixed annual or quarterly schedule. In practice, updates go through a Notice to Stakeholders, a public consultation period of around 60 days, and a comment-review phase that Health Canada says may last several months before a revised Hotlist is published. The version currently reflected on cosingchecker.com/regulations/ca/ is dated 2025-08-13; formulators working to Canadian requirements should treat any Hotlist copy as a snapshot and check canada.ca directly before finalizing a formulation, since a consultation already in progress will not yet appear in a dated snapshot.

The Cosmetic Notification Form

The Hotlist governs which substances can appear in a formulation. A separate obligation governs telling Health Canada that the product exists. Under section 30 of the Cosmetic Regulations, a Canadian manufacturer or importer of a cosmetic must notify Health Canada within 10 days of first selling that cosmetic in Canada, using the Cosmetic Notification Form (CNF). The notification includes the product's function, its full ingredient list, and contact details for the responsible party. Section 15.3 of the Cosmetic Regulations prohibits selling a cosmetic for which the required notification has not been filed, and amended notifications are required within 10 days of a material change to the formulation. The CNF is a separate filing from anything on the Hotlist - a fully Hotlist-compliant formulation can still be non-compliant in Canada if it was never notified.

How the Hotlist compares with the EU annexes

The EU's equivalent structure sits in Regulation (EC) 1223/2009: Annex II lists substances prohibited in cosmetic products, Annex III lists substances subject to restrictions, and Annexes IV, V and VI cover permitted colorants, preservatives and UV filters respectively. Unlike the Hotlist, the EU annexes are themselves the binding law - they are part of a directly applicable regulation, not an administrative aid pointing back to a general safety clause. The current dataset on cosingchecker.com/annex/ holds 1,739 Annex II entries and 373 Annex III entries, alongside 154 Annex IV, 54 Annex V and 33 Annex VI entries - a different shape from Canada's flat two-list structure, and Annex II alone is roughly three times the size of Canada's entire Hotlist (580 entries, prohibited and restricted combined).

The two systems also disagree on individual substances, and not just at the margins. Formaldehyde (CAS 50-00-0) is a listed EU Annex II entry (entry 1577) - banned outright as a cosmetic ingredient in the EU since Regulation (EU) 2019/831 moved it there from Annex V. The formaldehyde-releasing preservatives are separate Annex V entries, each with its own concentration limit on the preservative itself, and a finished product in which released formaldehyde reaches 0.001% must carry the warning "releases formaldehyde" under Regulation (EU) 2022/1181. In Canada, plain formaldehyde itself is a restricted, not prohibited, substance, permitted up to 5.0% in nail hardeners sold with shields and a warning label. A formulation compliant on one side of the border can be flatly prohibited on the other for the same ingredient at the same concentration.

Hydroquinone shows a narrower but still real gap. The EU treats it as an Annex II banned substance for general cosmetic use (entry 1339), with a single carved-out exception in Annex III entry 14: professional-use artificial nail systems, capped at 0.02% after mixing. Canada's Hotlist restricts hydroquinone across three use categories - hair dye colouring agent (0.3%), nail products (0.1%), and lash/brow adhesives (0.1%) - concentrations five to fifteen times higher than the EU's single permitted use, and for uses the EU does not permit hydroquinone in at all.

Triclosan is closer between the two markets but still not identical. The EU's Annex V entry 25 permits triclosan up to 0.3% in a defined list of product types (toothpaste, hand and body soap, non-spray deodorant, face powder, certain nail-cleaning products), with a child-under-3 warning specifically for toothpaste, following a 2024 amendment. Canada's restricted entry allows up to 0.3% in cosmetics generally and 0.03% in mouthwash specifically, with its own impurity-control conditions on dioxin and furan contaminants that the EU entry does not carry. The concentration ceilings land close together, but the product-type scoping and the warning triggers differ enough that a label compliant in one market needs a separate check against the other.

These are not edge cases found by digging - they are three of the better-known restricted substances in both systems, and each diverges in a different way: outright ban versus permitted-with-conditions, narrower versus broader use scope, and near-matching caps with different qualifying conditions. A formulator selling into both Canada and the EU needs to check both sources independently rather than assuming one market's clearance covers the other. cosingchecker.com/market-compare/ is built for exactly that side-by-side check.

Using the Hotlist without overreading it

The practical rule follows from the legal status described above. Treat a Hotlist entry as documentation of what Health Canada has published, not as a complete safety clearance or a complete prohibition list. A prohibited listing is a strong signal to remove the substance. A restricted listing means checking the specific product type, concentration and warning language against your formulation and label, not just a single percentage figure. And an ingredient's absence from the Hotlist answers only one question - whether Health Canada has flagged it through this specific tool - not whether section 16 of the Food and Drugs Act is satisfied for your product overall. For that broader determination, the FDA's general prohibition and the underlying Cosmetic Regulations remain the actual legal text, and the CNF filing is a separate, mandatory step regardless of what the Hotlist says about your ingredients.

Sources

• Cosmetic Ingredient Hotlist: Prohibited and Restricted Ingredients — https://www.canada.ca/en/health-canada/services/consumer-product-safety/cosmetics/cosmetic-ingredient-hotlist-prohibited-restricted-ingredients.html
• Cosmetic Ingredient Hotlist data table (prohibited and restricted substances) — https://www.canada.ca/en/health-canada/services/consumer-product-safety/cosmetics/cosmetic-ingredient-hotlist-prohibited-restricted-ingredients/hotlist.html
• Notification of Cosmetics: Guide for Cosmetic Notifications — https://www.canada.ca/en/health-canada/services/consumer-product-safety/cosmetics/notification-cosmetics/guide.html
• Food and Drugs Act, section 16 — https://laws-lois.justice.gc.ca/eng/acts/f-27/
• Cosmetic Regulations (C.R.C., c. 869) — https://laws-lois.justice.gc.ca/eng/regulations/C.R.C.,_c._869/
• Regulation (EC) No 1223/2009 on cosmetic products, Annexes II-VI — https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:02009R1223-20250301
• Commission Regulation (EU) 2024/996 amending Annex V as regards triclosan — https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32024R0996
• Commission Regulation (EU) No 344/2013 amending Annexes II and III (hydroquinone) — https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32013R0344